JCM
BBP icon

Jag Capital Management’s Virtus Biotech ETF BBP Stock Holding History

Jag Capital Management’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,625
Closed -$212K – 142
2025
Q1 		$212K Buy
3,625
+72
+2% +$4.42K 0.03% 122
2024
Q4 		$213K Sell
3,553
-475
-12% -$30K 0.03% 114
2024
Q3 		$253K Buy
+4,028
New +$251K 0.03% 111

Other funds holding BBP

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Jag Capital Management's BBP Position: Q2 2025 in Review

Jag Capital Management sold out of Virtus Biotech ETF (BBP) in Q2 2025, closing a stake of 3,625 shares — an estimated $212K sold.

Jag Capital Management first reported a position in BBP in Q3 2024 and held it in 3 quarters. The position peaked at $253K in Q3 2024. 15 funds tracked by Wall St. Rank hold BBP as of Q2 2025.

  • Jag Capital Management reported no remaining Virtus Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Jag Capital Management sold 3,625 Virtus Biotech ETF shares in Q2 2025, an estimated $212K.
  • Jag Capital Management first reported a position in Virtus Biotech ETF in Q3 2024 and held it in 3 quarters.
  • Jag Capital Management's Virtus Biotech ETF position peaked at $253K in Q3 2024.
  • 15 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2025.

Based on Jag Capital Management's 13F filing for Q2 2025, filed 28 Jul 2025.